Induction chemoradiotherapy for unresectable thymic tumors

Overview of the pathology of thymic neuroendocrine tumors

Evolution of thymic malignancy management in Japan

New options for neuroendocrine thymic tumors medical treatment

Pathological Features of Thymoma and Thymic Carcinoma with Therapeutic Implications

The Evolution of Thymic Surgery Through The Years in Art and History

From the Old to the New: The EURACAN Project

Use of Immune Checkpoint Inhibitors in Thymic epithelial tumors

Extended Surgical Resection for Stage III Thymic Tumors

The role of immune checkpoint blockade for treatment of thymic epithelial tumors - a delicate balance between efficacy and side effects

Disclosure:
The series “Dedicated to the 8th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2017)” was commissioned by the editorial office, Mediastinum without any sponsorship or funding. Pier Luigi Filosso served as the unpaid Guest Editor for the series.